US Patent 10588949 Factor IX polypeptide formulations

Patent 10588949 was granted and assigned to Bioverativ on March, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

105889490

Patent Inventor Names

Mark Brader0

Date of Patent

March 17, 2020

Patent Application Number

147761250

Date Filed

March 14, 2014

Patent Citations Received

‌

US Patent 12128092 Lyophilized factor IX formulations

‌

US Patent 11642398 Factor IX polypeptide formulations

Patent Primary Examiner

‌

Michael Szperka

Patent abstract

The present invention provides formulations comprising a Factor IX-FcRn Binding Partner (FIXFBP) polypeptide, and methods of administering FIXFBP.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10588949 Factor IX polypeptide formulations

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API